{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:51:42Z","timestamp":1787615502533,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Blood proteins can be used for biomarkers to monitor the progression of cognitive decline, even in the early stages of disease. In this study, we developed a liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS)-based blood test to identify plasma proteins that can be used to detect mild cognitive impairment (MCI) and Alzheimer\u2019s disease (AD). Using this system, we quantified plasma proteins using isotope-labeled synthetic peptides. A total of 192 patients, including 63 with AD, 71 with MCI, and 58 non-demented controls (NDCs), were analyzed. Multinomial regression and receiver operating characteristic (ROC) analyses were performed to identify specific combinations of plasma protein panels that could differentiate among NDCs, those with MCI, and those with AD. We identified eight plasma protein biomarker candidates that can be used to distinguish between MCI and AD. These biomarkers were associated with coagulation pathways, innate immunity, lipid metabolism, and nutrition. The clinical potential to differentiate cognitive impairment from NDC was assessed using area under the curve values from ROC analysis, which yielded values of 0.83 for males and 0.71 for females. This LC-MS-based plasma protein panel allows the pathophysiology of AD to be followed through detection of cognitive decline and disease progression markers.<\/jats:p>","DOI":"10.3390\/ijms241713064","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T08:58:54Z","timestamp":1692694734000},"page":"13064","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer\u2019s Disease Using Liquid Chromatography\u2013Tandem Mass Spectrometry"],"prefix":"10.3390","volume":"24","author":[{"given":"Makoto","family":"Inoue","sequence":"first","affiliation":[{"name":"Research Division, MCBI, 5-4-2 Toukoudai, Tsukuba 300-2635, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Research Division, MCBI, 5-4-2 Toukoudai, Tsukuba 300-2635, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Meno","sequence":"additional","affiliation":[{"name":"Research Division, MCBI, 5-4-2 Toukoudai, Tsukuba 300-2635, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[{"name":"Research Division, MCBI, 5-4-2 Toukoudai, Tsukuba 300-2635, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsumi","family":"Korenaga","sequence":"additional","affiliation":[{"name":"Research Division, MCBI, 5-4-2 Toukoudai, Tsukuba 300-2635, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Uchida","sequence":"additional","affiliation":[{"name":"Clinical Bioinformatics Initiative, Institute for Biomedical Research, MCBI, 5-4-2 Toukoudai, Tsukuba 300-2635, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild Cognitive Impairment: Clinical Characterization and Outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_2","first-page":"270","article-title":"Amyloid-\u03b2 Sequester Proteins as Blood-Based Biomarkers of Cognitive Decline","volume":"1","author":"Uchida","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_3","first-page":"85","article-title":"Serum Levels of Proteins Involved in Amyloid-\u03b2 Clearance Are Related to Cognitive Decline and Neuroimaging Changes in Mild Cognitive Impairment","volume":"11","author":"Liu","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward Defining the Preclinical Stages of Alzheimer\u2019s Disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia Prevention, Intervention, and Care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia Prevention, Intervention, and Care: 2020 Report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and Prediction of Clinical Alzheimer\u2019s Diagnosis Based on Plasma Signaling Proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neurobiolaging.2009.03.011","article-title":"Five out of 16 Plasma Signaling Proteins Are Enhanced in Plasma of Patients with Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"32","author":"Marksteiner","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Johnstone, D., Milward, E.A., Berretta, R., and Moscato, P. (2012). Alzheimer\u2019s Disease Neuroimaging Initiative Multivariate Protein Signatures of Pre-Clinical Alzheimer\u2019s Disease in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034341"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e053452","DOI":"10.1002\/alz.053452","article-title":"Prediction of future Alzheimer\u2019s Disease Neuroimaging Initiative Prediction of Future Alzheimer\u2019s Disease Dementia Using Plasma Phospho-tau Combined with Other Accessible Measures","volume":"17","author":"Palmqvist","year":"2021","journal-title":"Alzheimers Dement."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neurobiolaging.2010.02.016","article-title":"Increased Tissue Factor Pathway Inhibitor and Homocysteine in Alzheimer\u2019s Disease","volume":"33","author":"Piazza","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/ene.15762","article-title":"Blood Biomarkers in Mild Cognitive Impairment Patients: Relationship between Analytes and Progression to Alzheimer Disease Dementia","volume":"30","author":"Lima","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_13","first-page":"1797","article-title":"Plasma P-Tau231 and p-Tau217 as State Markers of Amyloid-\u03b2 Pathology in Preclinical Alzheimer\u2019s Disease","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1523\/JNEUROSCI.3562-15.2016","article-title":"Direct Transcriptional Effects of Apolipoprotein E","volume":"36","author":"Theendakara","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neurobiolaging.2011.04.013","article-title":"Microarray Analysis of the Astrocyte Transcriptome in the Aging Brain: Relationship to Alzheimer\u2019s Pathology and APOE Genotype","volume":"32","author":"Simpson","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5551\/jat.5405","article-title":"Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions","volume":"17","author":"Yamashita","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.5551\/jat.5652","article-title":"Effects of Statins on Serum Inflammatory Markers: The U.S. National Health and Nutrition Examination Survey 1999\u20132004","volume":"17","author":"Yoon","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/156720510790274392","article-title":"Serum Albumin Concentration and Cognitive Impairment","volume":"7","author":"Llewellyn","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/mp.2016.206","article-title":"Alpha-2 Macroglobulin in Alzheimer\u2019s Disease: A Marker of Neuronal Injury through the RCAN1 Pathway","volume":"22","author":"Varma","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jalz.2018.07.223","article-title":"An Updated Alzheimer Hypothesis: Complement C3 and Risk of Alzheimer\u2019s Disease\u2014A Cohort Study of 95,442 Individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013Brain Barrier Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"28163","DOI":"10.1074\/jbc.C112.360800","article-title":"Human Serum Albumin Can Regulate Amyloid-\u03b2 Peptide Fiber Growth in the Brain Interstitium: Implications for Alzheimer Disease","volume":"287","author":"Stanyon","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15990","DOI":"10.1074\/jbc.274.23.15990","article-title":"Endogenous Proteins Controlling Amyloid \u03b2-Peptide Polymerization: Possible Implications for \u03b2-Amyloid Formation in the Central Nervous System and in Peripheral","volume":"274","author":"Bohrmann","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","article-title":"Plasma Exchange for Alzheimer\u2019s Disease Management by Albumin Replacement (AMBAR) Trial: Study Design and Progress","volume":"5","author":"Boada","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","article-title":"Serum Albumin and Beta-Amyloid Deposition in the Human Brain","volume":"95","author":"Kim","year":"2020","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fuior, E.V., and Gafencu, A.V. (2019). Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235939"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1742-2094-9-192","article-title":"Apolipoprotein C-I Is an APOE Genotype-Dependent Suppressor of Glial Activation","volume":"9","author":"Cudaback","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1194\/jlr.M700518-JLR200","article-title":"Human Apolipoprotein C-I Expression in Mice Impairs Learning and Memory Functions","volume":"49","author":"Abildayeva","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/glia.22331","article-title":"Complement Component C3 and Complement Receptor Type 3 Contribute to the Phagocytosis and Clearance of Fibrillar A\u03b2 by Microglia","volume":"60","author":"Fu","year":"2012","journal-title":"Glia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Seabrook Complement C3 Deficiency Leads to Accelerated Amyloid \u03b2 Plaque Deposition and Neurodegeneration and Modulation of the Microglia\/Macrophage Phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Montecinos, L., Eskew, J.D., and Smith, A. (2019). What Is Next in This \u201cAge\u201d of Heme-Driven Pathology and Protection by Hemopexin? An Update and Links with Iron. Pharmaceuticals, 12.","DOI":"10.3390\/ph12040144"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jnc.12165","article-title":"Mechanisms of Neuroprotection by Hemopexin: Modeling the Control of Heme and Iron Homeostasis in Brain Neurons in Inflammatory States","volume":"125","author":"Hahl","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.neurobiolaging.2005.10.016","article-title":"Microvascular Pathology in the Aging Human Brain: Evidence That Senile Plaques Are Sites of Microhaemorrhages","volume":"27","author":"Cullen","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"590979","DOI":"10.3389\/fmolb.2020.590979","article-title":"Low Cerebrospinal Fluid Levels of Hemopexin Are Associated With Increased Alzheimer\u2019s Pathology, Hippocampal Hypometabolism, and Cognitive Decline","volume":"7","author":"Ashraf","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1128\/iai.61.12.5035-5043.1993","article-title":"Alpha-2-Macroglobulin Functions as an Inhibitor of Fibrinolytic, Clotting, and Neutrophilic Proteinases in Sepsis: Studies Using a Baboon Model","volume":"61","author":"Creasey","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E9687","DOI":"10.1073\/pnas.1811172115","article-title":"Blood-Derived Plasminogen Drives Brain Inflammation and Plaque Deposition in a Mouse Model of Alzheimer\u2019s Disease","volume":"115","author":"Baker","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13041-020-00677-3","article-title":"A2-Antiplasmin as a Potential Regulator of the Spatial Memory Process and Age-Related Cognitive Decline","volume":"13","author":"Kawashita","year":"2020","journal-title":"Mol. Brain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1073\/pnas.83.8.2363","article-title":"Amino Acid Sequence of Human Plasma Alpha 1B-Glycoprotein: Homology to the Immunoglobulin Supergene Family","volume":"83","author":"Ishioka","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Song, F., Poljak, A., Crawford, J., Kochan, N.A., Wen, W., Cameron, B., Lux, O., Brodaty, H., Mather, K., and Smythe, G.A. (2012). Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034078"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1021\/jf070337l","article-title":"Prediction of Molar Extinction Coefficients of Proteins and Peptides Using UV Absorption of the Constituent Amino Acids at 214 Nm to Enable Quantitative Reverse Phase High-Performance Liquid Chromatography-Mass Spectrometry Analysis","volume":"55","author":"Kuipers","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1074\/mcp.M800540-MCP200","article-title":"Multiple Reaction Monitoring-Based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma","volume":"8","author":"Kuzyk","year":"2009","journal-title":"Mol. Cell. Proteom."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13064\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:39:39Z","timestamp":1760128779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":42,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241713064"],"URL":"https:\/\/doi.org\/10.3390\/ijms241713064","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}